MaveriX Oncology

MaveriX Oncology is a biotechnology company focused on the discovery, development, and commercialization of targeted small-molecule cancer chemo-immunotherapies. The platform is designed to selectively deliver the tumor cell killing benefits of chemotherapy while generating an immune response to attack a wide range of cancers.